{"name":"Cue Biopharma","slug":"cue-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPeDlqQ000SDlwNXJUQ0k2U2d5bjVrVVRyWTI2Z2pPcGNKM2hZSndPdFQxaHU4SVdKdXN2VThMbjFEb0tmRUFUYXZTUE9heElQU09XeWtIaU5XSnJmMEhNYzdwTTRPVnluclNUUHlON00wRndHYWw0VkJFWEIxblgxTzMxd1gxOHVUVU1yaUsta2lnbXd6alVTdGRocy1WNzZ6Rjg0eDJ1LTNDNmZuTWh1cFF2NA?oc=5","date":"2026-04-08","type":"pipeline","source":"The Pharma Letter","summary":"Boehringer pays Cue Biopharma $7.5M to progress lead autoimmune asset - The Pharma Letter","headline":"Boehringer pays Cue Biopharma $7.5M to progress lead autoimmune asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNUjk5cFFyQnR2UVJRRFJYalpDbUlVTnJIOGdabHh3QlBRQ0xtSkNFVTRhMGM1WTk0U2d2VVF3UzhSRnBLdTZrVkN1cjVrbTBYRjZ5OUtoX3VHV1NnblJwMEhoZEh6cXJCSzdOMFlCVUVqRUJHZVJDVldCVk5DZ0l4bXBsNXhKdzBUVlVRVHpHNTlldi1SSnB0M3lCU2VvNmc?oc=5","date":"2026-04-02","type":"pipeline","source":"Fierce Biotech","summary":"Bayer radiology head takes top U.S. pharma spot—Chutes & Ladders - Fierce Biotech","headline":"Bayer radiology head takes top U.S. pharma spot—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQZFB1SnZyVVZfUWtXRldSbkVIZkhrMjhtNzRzbHVjSVc1ejMtc2VtZGoxeVh1RHU0elFmTjBPZEdsSnVTVk0yX2pFdjE2anBqLUhUUjRaT0JmeXZrR2hKX0NNTjFWZnF4aWkwZkNTaXA3aklMajJ5LVFOYmQxNS1lXzg4aHBfNzB0?oc=5","date":"2026-03-27","type":"pipeline","source":"Stock Titan","summary":"Cue Biopharma swaps CEOs as Lucinda Warren takes interim post - Stock Titan","headline":"Cue Biopharma swaps CEOs as Lucinda Warren takes interim post","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPaHdoX1BFcExZOUZaZjVBZmE5a194eHJnMlRYQkU3UkZQM01zNzJfVTBXQmFKOHgwLV9lNU9sdXJLT0piUno5MUJmYXNZQm9rOEIxRHNtem0xTTY0aW0wSHg1MXFieDhCSml0SGx5d0pyakRYNXd5d2prUDcydF9GNzZBdVpHRVlzUENIWlJVTjB3QXZmcHQw?oc=5","date":"2026-02-20","type":"pipeline","source":"BioXconomy","summary":"Biotech companies appoint new chief finance heads - BioXconomy","headline":"Biotech companies appoint new chief finance heads","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQNHRNcUVVZlNvV21UWEdmTXRVenhMbEg5UU8yZ1hwWTM3ZjFTQi1sUEV2b1FNZzFUMVFrNjU1Z0xleUpsUVJpOTcwZWp2Y0M4d01XRzlPdjQyM1ZMMFBwMUYtQ1FFRG0tWWIwV2FpellHR0l1M0ZPMnlHNTVhaVB1RmRKSXptallncDZqN213bTVDX3VZdUVGWlFCTzhVOVdCbHFDNlRPOGkzd3lBd3BCdlBWbllsUWJa?oc=5","date":"2026-02-12","type":"pipeline","source":"Stock Titan","summary":"30-year pharma veteran Lucinda Warren to oversee finances at Cue Biopharma - Stock Titan","headline":"30-year pharma veteran Lucinda Warren to oversee finances at Cue Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBLbGlaM1o5dVpLa093ajNtMDR1VFpOTHhtYUcxN1NBb2t1R0o0ZkRZdkhvX0RDZzVNYUs2LVh2QUpXVENHQWZ0NkxEczBfSXd3QW1j?oc=5","date":"2026-01-27","type":"pipeline","source":"FirstWord Pharma","summary":"Boehringer inks €1.05B pact with Simcere for preclinical IBD bispecific - FirstWord Pharma","headline":"Boehringer inks €1.05B pact with Simcere for preclinical IBD bispecific","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxONGRscGV6TUw0N0NqbEg2d3o2LTM2clJUUTdfcVRHTVVUTEg0YVQtSnZEWUZwY2NFOTN3UDZHSV83eExGYlFMdUdhVmFteUNUWUtQSWFzdG1EVTg5eThzSFh6SGFLTmlIdGU3ZEtCYjlIaHFFNXBHTmJTTlRRQ1dKSg?oc=5","date":"2025-12-03","type":"deal","source":"labiotech.eu","summary":"Boehringer Ingelheim's pipeline activity: A busy year of dealmaking for the German pharma in 2025 - labiotech.eu","headline":"Boehringer Ingelheim's pipeline activity: A busy year of dealmaking for the German pharma in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOM2dCUHVlYjB1UnhkV0h5aVhYWkN3d3VTS2NzTFg4OFFWZEFROFNMWmZBSm1kRnRpZ2VrNXRZY3UwdlZmWGJNdzlyRVU0cWtNRnM0YmJtdkpZQmptZXZPeUVNN3E1aVE1SVlnYVZweWh4eDc5dVhyOVZRQnRuSWYtVDN0bzduRkw3ZXh4ck13Z0pPTUZjTy1PeG9vOEhiRmp5aGV0NHlmdjlCZw?oc=5","date":"2025-10-15","type":"deal","source":"BioSpace","summary":"Boehringer Ingelheim Bets up to Nearly $1B in ADC Play With AimedBio Deal - BioSpace","headline":"Boehringer Ingelheim Bets up to Nearly $1B in ADC Play With AimedBio Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNbURMbHA5QUFwNXRwMlU0UVFQcFc4OENfTXFmMEF0ZDJXd0c2Ri03NUJDNzZKTV93OFBzRHpqb0oxZVNPTnBLNDFUaXViV29UZjc2cjN0RkoxMS1DVXVPaFFzYkQwNnVEVGlJdXNyWTFtVzgwWFFkbVdnajB3cHJvYVgwUG53Zy1lVjYtVEE2T1E?oc=5","date":"2025-10-03","type":"pipeline","source":"Fierce Biotech","summary":"GSK chief steps down in stunning move—Chutes & Ladders - Fierce Biotech","headline":"GSK chief steps down in stunning move—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPVGxya29RMXktNU1rZkhGZ2RnUTRsaW80di1mZU5UaFVXRVFoSDNwQXFUcldSRG40cDZ1RHdvdl9JWWpNc0E3UFVJTWVqUHNRUGVxRnZOemZyeDNzZXNhNlN6NWtNV096M0NKYVRfU2lFenFUa1JiTVoxZXAyazZ6eWZOVnZnZUlJM0FLQUpFV0c5Nm1PU29haHcyZElCRlpZc3ppMzA1S0NlY2k1X3lVMWVCSHlINW9nNWdvdEUwT0hxd080c3B1QzZ4R0ZqbmJXY2ZTNjRPejhBTENUSDR1VkFqcmVyZmVQdVhpOUo4cjlQTHptN1FkRmRnY1hkd3ZsSElib1J0TzBTbVBGWW1QSTFGLWhWMG1OUGJSZXN3UUE?oc=5","date":"2025-09-30","type":"pipeline","source":"prnewswire.com","summary":"HPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034, Driven by Rising Incidence and Treatment Innovation | DelveInsight - prnewswire.com","headline":"HPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034, Driven by Rising Incidence and Treatment Inno","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxON3haaElHU09WM2UxVFAtWGQyRUtONkJKSURwc1E0bWVjVnRTVTRTVklWSFBiZURWLWgtQWhEcGFBNmZLM0FhTFFZeE5tWE90dnRVRzk2bVlVVFEzS3dtX3c5T3Y3allKd1E2UEhUbzJGdnk0SlR4Z2hsTkxHTy1XNTljamJJcnJ2WG5YVUd2RS1pWlE4aHp0WFR2TGU1WGcxa3Fabk0walIxdGZCXzg3amhpTkpJSm12ajR5akpkTVpuc1RaSUZKek1yZEc1WVFGWVkwSnZBX1Q2T0EtUmlaREM4eVl4T3RoRE1iZmpkTTk0VUM2NXRhdkdxc3ZNOEJMTVc3Zk5HcUp0bzdESU42OFN0cmQ1ZDFYX0JzdVZBV0gtZjY0cDQzUl9sQ01fSllFcjhhRA?oc=5","date":"2025-07-10","type":"trial","source":"GlobeNewswire","summary":"Interleukin-2 Inhibitors Clinical Trial Pipeline - GlobeNewswire","headline":"Interleukin-2 Inhibitors Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPYVFndHc2LUQ3V1JXVzh0Ykt2NzE4dUhUVkJyYlB3OGVrcWR2VnI1NE1MWUFjNXloMkxJXzNoaEUxaDFEM2ppd3NyY3c0ZHExWHBiUTJCcTdQZ3JVbWo2X19Fb0RzOUVJbUVScUh4b2NvWVFpSmRvVEVmQ1VSR1d4blVvNEZ4enRmQ3VKR3hXb3hNcjNIaTJVODJlNFFPdkR4d18xLWtNZHZxbXNkaU5kQ1FLTUFQYm9IX1Juckpiay1iZEJFM08zMUNCX2xMQQ?oc=5","date":"2025-04-15","type":"deal","source":"Contract Pharma","summary":"Boehringer Ingelheim, Cue Biopharma Partner to Commercialize Therapy for Immune Diseases - Contract Pharma","headline":"Boehringer Ingelheim, Cue Biopharma Partner to Commercialize Therapy for Immune Diseases","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}